An Open-Labeled, Randomized Clinical Trial to Study the Performance and Safety of an Intravenous Line Organizer (IVO) in a Tertiary Care Hospital
Year: 2024; Volume: 4; Issue: 4; Page No: 3 – 15
Article Type: Original Article
Authors: Baburao Vikram1*, Renuka Venkatesh2, Shruthi Shetty3, Priyanka DS4, Saveen Kumar S5, Derryl Burke*6
https://doi.org/10.55349/ijmsnr.202444315
Affiliations: *1Director, Pharexcel Consulting Private Limited, Tata New Haven, Seshagirirao Palya Village, Dasanpura Hobli, Bengaluru North Taluka, Karnataka, India. Email ID: info@pharexcelconsulting.com
2Professor & HOD, Department of Community Medicine, Sapthagiri Institute of Medical Sciences and Research Centre, Navy Layout, Chikkabanavara, Bengaluru, Karnataka, India. Email ID: renu_70s@yahoo.co.in
3Associate Professor, Department of Community Medicine, Sapthagiri Institute of Medical Sciences and Research Centre, Navy Layout, Chikkabanavara, , Karnataka, India. Email ID: drshruthis2020@gmail.com
4Assistant Professor, Department of Community Medicine, Sapthagiri Institute of Medical Sciences and Research Centre, Navy Layout, Chikkabanavara, Bengaluru, Karnataka, India. Email ID: drpriyankamahesh1990@gmail.com
5Annamalai University, Annamalai Nagar, Chidambaram, Tamil Nadu India. Email ID: saveenkumar2110@gmail.com
6Independent Researcher, Mine Road, Bolton East, Quebec J0E IG0, Canada. Email ID: readaround@hotmail.com
How to cite this article: Vikram B, Venkatesh R, Shetty S, Priyanka DS, Kumar SS, Burke D. An Open-Labeled, Randomized Clinical Trial to Study the Performance and Safety of an Intravenous Line Organizer (IVO) in a Tertiary Care Hospital. Int J Med Sci and Nurs Res 2024;4(4):3–15. DOI: 10.55349/ijmsnr.202444315 |
Article Summary: Submitted: 07-October-2024 Revised: 28-November-2024 Accepted: 12-December-2024 Published: 30-December -2024
Abstract
Background: Medical line and tube entanglement poses a significant threat causing unintentional consequences to the patients.
Objectives: To study the clinical performance and safety of the IVO (intravenous line organizer) for providing patient autonomy, mobility, and comfort.
Methods: Patients aged <18 years (pediatrics) and >18 years (adults) who were admitted to the hospital for treatment were included in the study. Tools like the Global Scale, Ease of Operability Scale, Severity of Intravenous Line Entanglement by Medical Line Entanglement Scale, Subjective Presumption Questionnaire, and Skin Irritation Scale, and adverse and serious adverse events were assessed and analyzed.
Results: A total of 120 subjects who participated in the study were randomized into Groups-A (with IVO) and B (without IVO). The majority of patients in Group-A demonstrated better autonomy toward lines and tubes compared to Group-B in both adult and pediatric populations (86.3% vs 20%: Pediatric, 83.3% vs 26.6%: Adult), p<0.0001. Also, on mobility the Group-A patients reported improved movements with reduced restriction compared to Group-B (76.3% vs 26.6%, p<0.0001). Further, on the design and usability of IVO, 73.3% of patients in Group-A showed greater interest in the operability and usability compared to 27% in Group-B. No entanglement was reported in Group-A compared to the 12 (10%) patients facing potential harm of levels 2 & 3 who were in the standard-of-care group (without IVO). No significant adverse events were reported in patients using IVO.
Conclusion: The IVO provided patients with the safe organization of intravenous tubes with greater autonomy, mobility, and comfort in managing the IV lines.
Keywords: Intravenous Line Organizer, Autonomy, Mobility, Comfort, Entanglement
Source of funding: None
Conflict of Interest: Nothing declared by the authors
Corresponding Author:
Mr. Derryl Burke,
Independent Researcher,
68, Mine Road,
Bolton East, Quebec J0E IG0,
Canada.
Email ID: readaround@hotmail.com
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‑Non-Commercial‑ShareAlike 4.0 International License, which allows others to remix, tweak, and build upon the work non‑commercially, as long as appropriate credit is given, and the new creations are licensed under the identical terms.